Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

An ADAR1 dsRBD3-PKR kinase domain interaction on dsRNA inhibits PKR activation

K. Sinigaglia, A. Cherian, Q. Du, V. Lacovich, D. Vukić, J. Melicherová, P. Linhartova, L. Zerad, S. Stejskal, R. Malik, J. Prochazka, N. Bondurand, R. Sedláček, MA. O'Connell, LP. Keegan

. 2024 ; 43 (8) : 114618. [pub] 20240814

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24019262

Adar null mutant mouse embryos die with aberrant double-stranded RNA (dsRNA)-driven interferon induction, and Adar Mavs double mutants, in which interferon induction is prevented, die soon after birth. Protein kinase R (Pkr) is aberrantly activated in Adar Mavs mouse pup intestines before death, intestinal crypt cells die, and intestinal villi are lost. Adar Mavs Eifak2 (Pkr) triple mutant mice rescue all defects and have long-term survival. Adenosine deaminase acting on RNA 1 (ADAR1) and PKR co-immunoprecipitate from cells, suggesting PKR inhibition by direct interaction. AlphaFold studies on an inhibitory PKR dsRNA binding domain (dsRBD)-kinase domain interaction before dsRNA binding and on an inhibitory ADAR1 dsRBD3-PKR kinase domain interaction on dsRNA provide a testable model of the inhibition. Wild-type or editing-inactive human ADAR1 expressed in A549 cells inhibits activation of endogenous PKR. ADAR1 dsRNA binding is required for, but is not sufficient for, PKR inhibition. Mutating the ADAR1 dsRBD3-PKR contact prevents co-immunoprecipitation, ADAR1 inhibition of PKR activity, and co-localization of ADAR1 and PKR in cells.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019262
003      
CZ-PrNML
005      
20241024111401.0
007      
ta
008      
241015s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.celrep.2024.114618 $2 doi
035    __
$a (PubMed)39146181
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Sinigaglia, Ketty $u Central European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czechia; National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Kamenice 5, 625 00 Brno, Czechia
245    13
$a An ADAR1 dsRBD3-PKR kinase domain interaction on dsRNA inhibits PKR activation / $c K. Sinigaglia, A. Cherian, Q. Du, V. Lacovich, D. Vukić, J. Melicherová, P. Linhartova, L. Zerad, S. Stejskal, R. Malik, J. Prochazka, N. Bondurand, R. Sedláček, MA. O'Connell, LP. Keegan
520    9_
$a Adar null mutant mouse embryos die with aberrant double-stranded RNA (dsRNA)-driven interferon induction, and Adar Mavs double mutants, in which interferon induction is prevented, die soon after birth. Protein kinase R (Pkr) is aberrantly activated in Adar Mavs mouse pup intestines before death, intestinal crypt cells die, and intestinal villi are lost. Adar Mavs Eifak2 (Pkr) triple mutant mice rescue all defects and have long-term survival. Adenosine deaminase acting on RNA 1 (ADAR1) and PKR co-immunoprecipitate from cells, suggesting PKR inhibition by direct interaction. AlphaFold studies on an inhibitory PKR dsRNA binding domain (dsRBD)-kinase domain interaction before dsRNA binding and on an inhibitory ADAR1 dsRBD3-PKR kinase domain interaction on dsRNA provide a testable model of the inhibition. Wild-type or editing-inactive human ADAR1 expressed in A549 cells inhibits activation of endogenous PKR. ADAR1 dsRNA binding is required for, but is not sufficient for, PKR inhibition. Mutating the ADAR1 dsRBD3-PKR contact prevents co-immunoprecipitation, ADAR1 inhibition of PKR activity, and co-localization of ADAR1 and PKR in cells.
650    12
$a adenosindeaminasa $x metabolismus $x genetika $7 D000243
650    12
$a kinasa eIF-2 $x metabolismus $7 D019892
650    12
$a dvouvláknová RNA $x metabolismus $7 D012330
650    12
$a proteiny vázající RNA $x metabolismus $x genetika $7 D016601
650    _2
$a lidé $7 D006801
650    _2
$a zvířata $7 D000818
650    _2
$a myši $7 D051379
650    _2
$a vazba proteinů $7 D011485
650    _2
$a aktivace enzymů $7 D004789
650    _2
$a buňky A549 $7 D000072283
650    _2
$a proteinové domény $7 D000072417
655    _2
$a časopisecké články $7 D016428
700    1_
$a Cherian, Anna $u Central European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czechia; National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Kamenice 5, 625 00 Brno, Czechia
700    1_
$a Du, Qiupei $u Central European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czechia; National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Kamenice 5, 625 00 Brno, Czechia
700    1_
$a Lacovich, Valentina $u Central European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czechia
700    1_
$a Vukić, Dragana $u Central European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czechia; National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Kamenice 5, 625 00 Brno, Czechia
700    1_
$a Melicherová, Janka $u Central European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czechia; National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Kamenice 5, 625 00 Brno, Czechia
700    1_
$a Linhartova, Pavla $u Central European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czechia
700    1_
$a Zerad, Lisa $u Laboratory of Embryology and Genetics of Human Malformation, Imagine Institute, INSERM UMR 1163, Université de Paris Cité, 75015 Paris, France
700    1_
$a Stejskal, Stanislav $u Central European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czechia
700    1_
$a Malik, Radek $u Laboratory of Epigenetic Regulation, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, 142 20 Prague, Czechia
700    1_
$a Prochazka, Jan $u Institute of Molecular Genetics of the Czech Academy of Sciences, Prumyslova 595, 252 50 Vestec, Czechia
700    1_
$a Bondurand, Nadège $u Laboratory of Embryology and Genetics of Human Malformation, Imagine Institute, INSERM UMR 1163, Université de Paris Cité, 75015 Paris, France
700    1_
$a Sedláček, Radislav $u Institute of Molecular Genetics of the Czech Academy of Sciences, Prumyslova 595, 252 50 Vestec, Czechia
700    1_
$a O'Connell, Mary A $u Central European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czechia. Electronic address: mary.oconnell@ceitec.muni.cz
700    1_
$a Keegan, Liam P $u Central European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czechia. Electronic address: liam.keegan@ceitec.muni.cz
773    0_
$w MED00188029 $t Cell reports $x 2211-1247 $g Roč. 43, č. 8 (2024), s. 114618
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39146181 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024111355 $b ABA008
999    __
$a ok $b bmc $g 2201856 $s 1231235
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 43 $c 8 $d 114618 $e 20240814 $i 2211-1247 $m Cell reports $n Cell Rep $x MED00188029
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...